Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | SRC | P12931 | 2/20 | 0.84 |
| ▸ | APP | P05067 | 8/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.65 |
| ▸ | TTR | P02766 | 6/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.65 |
| ▸ | HPGD | P15428 | 4/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.65 |
| ▸ | POLB | P06746 | 3/20 | 0.65 |
| ▸ | GAA | P10253 | 3/20 | 0.65 |
| ▸ | RECQL | P46063 | 2/20 | 0.65 |
| ▸ | MMP1 | P03956 | 2/20 | 0.65 |
| ▸ | THRB | P10828 | 2/20 | 0.65 |
| ▸ | APEX1 | P27695 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | LCK | P06239 | 2/20 | 0.65 |
| ▸ | FYN | P06241 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chicoric Acid SCHEMBL13772650 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL30518333 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL964775 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Cichoric Acid SCHEMBL29349701 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL30995918 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Cichoric Acid SCHEMBL29385936 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL963407 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL961606 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL21176639 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Cichoric Acid SCHEMBL15532218 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11717549-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| US-20200171331-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CAFFEIC ACID CHELATES | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2020-06-04 | — | — | US | disclosed |
| WO-2020077428-A1 | COMPOUNDS, USE OF COMPOUNDS IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, AND PHARMACEUTICAL COMPOSITION COMPRISING 7,11B-DIHYDRO-6H-INDENO[2,1-C]CHROMENE-3,6A,9,10-TETROL, NEUTRAL OR IONIZED DERIVATIVES OR ANALOGUES THEREOF, FOR SENOLYTIC PREVENTION AND/OR THERAPY PURPOSES | UNIÃO BRASILEIRA DE EDUCAÇÃO E ASSISTÊNCIA - MANTENEDORA DA PUCRS (BR) | 2020-04-23 | — | — | WO | disclosed |
| US-20190223481-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2019-07-25 | — | — | US | disclosed |
| US-20170258861-A1 | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | SQUIRES MERYL J (US) | 2017-09-14 | — | — | US | disclosed |
| US-9662360-B2 | Treatment of herpes, pseudomonas, staph, and hepatitis | MERITUS CORPORATION (DM) | 2017-05-30 | — | — | US | disclosed |
| US-9491962-B2 | Use of chicoric acid and derivatives for regulating skin pigmentation | NESTEC S.A. (CH) | 2016-11-15 | — | — | US | disclosed |
| US-9491962-B2 | Use of chicoric acid and derivatives for regulating skin pigmentation | NESTEC S.A. (CH) | 2016-11-15 | — | — | US | disclosed |
| US-20160151436-A1 | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | MERITUS CORPORATION (DM) | 2016-06-02 | — | — | US | disclosed |
| US-9192554-B2 | Use of chicoric acid and lactic bacterium in food supplement for regulating skin pigmentation | NESTEC S.A. (CH) | 2015-11-24 | — | — | US | disclosed |
| WO-2012000962-A2 | USE OF CHICORIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR REGULATING SKIN PIGMENTATION | NESTEC S.A. (CH) | 2012-01-05 | — | — | WO | disclosed |
| WO-2012000957-A1 | USE OF CHICORIC ACID AND LACTIC BACTERIUM FOR REGULATING SKIN PIGMENTATION | NESTEC S.A. (CH) | 2012-01-05 | — | — | WO | disclosed |
| WO-2012000954-A1 | USE OF CHICORIC ACID AND DERIVATIVES FOR REGULATING SKIN PIGMENTATION | NESTEC S.A. (CH) | 2012-01-05 | — | — | WO | disclosed |
| US-20110280848-A1 | COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF | NESTEC S.A. (CH) | 2011-11-17 | — | — | US | disclosed |
| US-20110280848-A1 | COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF | NESTEC S.A. (CH) | 2011-11-17 | — | — | US | disclosed |
| US-20100303935-A1 | Medicinal Composition | MCGINLEY PARTNERS, LLC (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100303935-A1 | Medicinal Composition | MCGINLEY PARTNERS, LLC (US) | 2010-12-02 | — | — | US | disclosed |
| WO-2010086322-A1 | COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF | NESTEC S.A. (CH) | 2010-08-05 | — | — | WO | disclosed |
| EP-2210504-A1 | Composition comprising chicoric acid and/or derivatives thereof | Nestec S.A. (CH) | 2010-07-28 | — | — | EP | disclosed |
| US-20090191288-A1 | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases | SQUIRES MERYL J | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160151436-A1 | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | NISCH, CUTA, HRH1 | HSD17B10 1652/4885TDP1 4114/4885ALOX15 1816/4885 |
| US-20170258861-A1 | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | NISCH, CUTA, HRH1 | HSD17B10 1652/4885TDP1 4114/4885ALOX15 1816/4885 |
| US-20090191288-A1 | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases | ASPH, KCNH3, PRPH | HSD17B10 1798/4885TDP1 4091/4885ALOX15 1448/4885 |
| US-20100303935-A1 | Medicinal Composition | MUSK, TNNC1, ACHE | HSD17B10 3405/4885TDP1 1158/4885ALOX15 318/4885 |
| US-20200171331-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CAFFEIC ACID CHELATES | PROC, PRCP, CTSG | HSD17B10 1863/4885TDP1 3124/4885ALOX15 3099/4885 |
| US-11717549-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | HSD17B10 827/4885TDP1 1913/4885ALOX15 2972/4885 |
| US-20110280848-A1 | COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF | LCT, LDHA, SI | HSD17B10 595/4885TDP1 1032/4885ALOX15 2217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.